Oral presentation features open label extension PALSONIFY™ (paltusotine) data, reinforcing its best-in-class potential in acromegaly following ...

Jill Sisco, president of Acromegaly Community, opposes the Most Favored Nation policy that would limit rare disease patients' access to innovative therapies.

Among patients with acromegaly, women reported a significantly higher symptom burden, more musculoskeletal comorbidities, higher perceived need for treatment, and poorer physical and mental quality of ...

Please provide your email address to receive an email when new articles are posted on . Adults with acromegaly may be prone to developing nodular thyroid disease and advanced nodule growth, according ...

ACRO/TRUTH Provides Authentic Patient Perspectives, Peer-Reviewed Data on Treatment-Related Symptoms, Side Effects and Quality-of-Life Impact of Current Acromegaly Standard-of-Care SAN DIEGO, Aug. 08, ...

Acromegaly is one of those diseases that immediately caught our attention when we first heard about it in medical school. We stared at the textbook pictures of big hands and coarse faces—maybe a very ...

Please provide your email address to receive an email when new articles are posted on . “It is well known that insulin-like growth factor I has mitogenic and antiapoptotic activity,” Muhammed Kizilgul ...

BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare ...

Acromegaly is an insidious disease that, in most cases, is a result of a pituitary adenoma that hypersecretes growth hormone (GH). The goals of therapy are to control excess GH secretion and limit, if ...